...
首页> 外文期刊>American Journal of Physiology >Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes.
【24h】

Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes.

机译:血小板衍生的生长因子-BB和Ets-1转录因子负调控多个平滑肌细胞分化标记基因的转录。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Platelet-derived growth factor (PDGF)-BB, a potent mitogen for mesenchymal cells, also downregulates expression of multiple smooth muscle (SM) cell (SMC)-specific markers. However, there is conflicting evidence whether PDGF-BB represses SMC marker expression at a transcriptional or posttranscriptional level, and little is known regarding the mechanisms responsible for these effects. Results of the present studies provide clear evidence that PDGF-BB treatment strongly repressed SM alpha-actin, SM myosin heavy chain (MHC), and SM22alpha promoters in SMCs. Of major significance for resolving previous controversies in the field, we found PDGF-BB-induced repression of SMC marker gene promoters in subconfluent, but not postconfluent, cultures. Treatment of postconfluent SMCs with a tyrosine phosphatase inhibitor restored PDGF-BB-induced repression, whereas treatment of subconfluent SMCs with a tyrosine kinase blocker abolished PDGF-BB-induced repression, suggesting that a tyrosine phosphorylation event mediates cell density-dependent effects. On the basis of previous observations that Ets-1 transcription factor is upregulated within phenotypically modulated neointimal SMCs, we tested whether Ets-1 would repress SMC marker expression. Consistent with this hypothesis, results of cotransfection experiments indicated that Ets-1 overexpression reduced transcriptional activity of SMC marker promoter constructs in SMCs, whereas it increased activity of SM alpha-actin promoter in endothelial cells. PDGF-BB treatment increased expression of Ets-1 in cultured SMCs, and SM alpha-actin mRNA expression was reduced in multiple independent clones of SMCs stably transfected with an Ets-1-overexpressing construct. Taken together, results of these experiments provide novel insights regarding possible mechanisms whereby PDGF-BB and Ets-1 may contribute to SMC phenotypic switching associated with vascular injury.
机译:血小板衍生的生长因子(PDGF)-BB是间充质细胞的有效促分裂原,它也下调了多个平滑肌(SM)细胞(SMC)特异性标志物的表达。但是,有相互矛盾的证据表明PDGF-BB是在转录水平还是转录后水平抑制SMC标记物的表达,关于引起这些作用的机制知之甚少。本研究的结果提供了明确的证据,PDGF-BB治疗可强烈抑制SMC中的SMα-肌动蛋白,SM肌球蛋白重链(MHC)和SM22alpha启动子。对于解决该领域以前的争议具有重要意义,我们发现PDGF-BB诱导的亚汇合(但非汇合后)培养物中的SMC标记基因启动子受阻。用酪氨酸磷酸酶抑制剂治疗汇合后的SMC恢复了PDGF-BB诱导的阻抑,而用酪氨酸激酶阻滞剂治疗亚汇合的SMC取消了PDGF-BB诱导的阻抑,表明酪氨酸磷酸化事件介导了细胞密度依赖性效应。基于以前的观察,Ets-1转录因子在表型调节的新内膜SMC中上调,我们测试了Ets-1是否会抑制SMC标记物的表达。与该假设一致,共转染实验的结果表明Ets-1过表达降低了SMC中SMC标记启动子构建体的转录活性,而增加了内皮细胞中SMα-肌动蛋白启动子的活性。 PDGF-BB处理可增加培养的SMC中Ets-1的表达,并且在多个独立克隆的SMC中稳定表达Ets-1的Es-1的表达可降低SMα-actinmRNA的表达。综上所述,这些实验的结果提供了有关PDGF-BB和Ets-1可能有助于与血管损伤相关的SMC表型转换的可能机制的新颖见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号